References
- Matuchansky C. Cholecystokinoma syndrome and diarrhea. Scand J Gastroenterol. 2017;52:467.
- Rehfeld JF, Federspiel B, Agersnap M, et al. The uncovering and characterization of a CCKoma syndrome in enteropancreatic neuroendocrine tumor patients. Scand J Gastroenterol. 2016;51:1172–1178.
- Rehfeld JF, Federspiel B, Bardram L. A neuroendocrine tumor syndrome from cholecystokinin secretion. N Engl J Med. 2013;368:1165–1166.
- Schneider R, Waldmann J, Swaid Z, et al. Calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entity. Pancreas. 2011;40:213–221.
- Larsson L-I, Grimelius L, Håkanson R, et al. Mixed endocrine pancreatic tumors producing several peptide hormones. Am J Pathol. 1975;79:271–284.
- Rehfeld JF, Sun G, Christensen T, et al. The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33. J Clin Endocrinol Metab. 2001;86:251–258.
- Chen D, Zhao C-M, Håkanson R, et al. Altered control of gastric acid secretion in gastrin-cholecystokinin double mutant mice. Gastroenterology. 2004;126:476–487.
- Rehfeld JF, Agersnap M. Unsulfated cholecystokinin: an overlooked hormone? Regul Pept. 2012;173:1–5.
- Agersnap M, Rehfeld JF. Nonsulfated cholecystokinins in the small intestine of pigs and rats. Peptides. 2015;71:121–127.
- Agersnap M, Zhang MD, Harkany T, et al. Nonsulfated cholecystokinins in cerebral neurons. Neuropeptides. 2016;60:37–44.
- Rehfeld JF. Posttranslational attenuation of peptide gene expression. FEBS Lett. 1990;268:1–4.
- Rehfeld JF, Bardram L, Blanke S, et al. Peptide hormone processing in tumours: biogenetic and diagnostic implications. Tumour Biol. 1993;14:174–183.
- Rehfeld JF. Cholecystokinin expression in tumors:biogenetic and diagnostic implications. Future Oncol. 2016;12:2135–2147.
- Rehfeld JF. Accurate measurement of cholecystokinin in plasma. Clin Chem. 1998;44:991–1001.